Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ivan Lumu"'
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background After completion of TB treatment patients may remain at risk of co-morbidity and mortality. We determined the survival and predictors of all-cause mortality after completing TB treatment among ART-experienced patients. Methods Thi
Externí odkaz:
https://doaj.org/article/a51eeeffcf91410d8fdea6326d488a40
Autor:
Jerome Nyhalah Dinga, Severin Kabakama, Dieudonne Lemuh Njimoh, Julius Ebua Chia, Imran Morhason-Bello, Ivan Lumu
Publikováno v:
Vaccines, Vol 12, Iss 1, p 34 (2023)
Mass vaccination against COVID-19 is the best method to ensure herd immunity in order to curb the effect of the pandemic on the global economy. It is therefore important to assess the determinants of COVID-19 vaccine acceptance and hesitancy on a glo
Externí odkaz:
https://doaj.org/article/29b77d86d9484e21809426efe4aab1dc
Autor:
Severin Kabakama, Eveline T. Konje, Jerome Nyhalah Dinga, Colman Kishamawe, Imran Morhason-Bello, Peter Hayombe, Olufela Adeyemi, Ernest Chimuka, Ivan Lumu, John Amuasi, Theophilus Acheampong, Tafadzwa Dzinamarira
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 7, Iss 7, p 130 (2022)
Rates of vaccination against COVID-19 remain lower in sub-Saharan Africa than in other low and middle-income regions. This is, in part, attributed to vaccine hesitancy, mainly due to misinformation about vaccine origin, efficacy and safety. From Augu
Externí odkaz:
https://doaj.org/article/2ded22f0c5d1411fb9fd6219aa3f79cc
Publikováno v:
AIDS. 36:1791-1800
The study investigated the durability of switched therapy and factors associated with the viral rebound among patients on second-line antiretroviral therapy (ART) in Uganda.A retrospective dynamic cohort of adults initiated on second-line ART after v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac8eaae77486ec900d245e8d39482571
https://doi.org/10.1097/qad.0000000000003340
https://doi.org/10.1097/qad.0000000000003340
BackgroundAfter completion of TB treatment patients may remain at-risk of complications and mortality. We determined the survival and predictors of all-cause mortality after completing TB treatment among ART experienced patients.MethodsThis was a ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f10ffe4899af167c186e1aee09bfa40
https://doi.org/10.1101/2022.05.18.22275233
https://doi.org/10.1101/2022.05.18.22275233
